BioSpace News Archive

Policy

The Danish Coop Bans Fluorinated Compounds in All Cosmetics

As the first retail group in the world, Coop in Denmark has decided to discontinue all purchases of cosmetics and personal care products containing harmful fluorinated substances.

March 9, 2019
·
2 min read
Drug Development

Vedolizumab (Entyvio®) Achieves Superior Rates of Clinical Remission vs. Adalimumab (Humira®) in First Ever Head-to-Head Biologic Clinical Study in Ulcerative Colitis

Vedolizumab superior to adalimumab in achieving clinical remission and mucosal healing at week 52 in patients with moderately to severely active ulcerative colitis

March 9, 2019
·
14 min read
Policy

Information Update - Multiple Losartan-containing drugs voluntarily recalled because of potential for nitrosamine impurity

Health Canada is advising Canadians that multiple lots of Losartan-containing drugs are being voluntarily recalled by Teva Canada, Apotex Inc., Pharmascience Inc., and Pro Doc Limitée because of the potential for a nitrosamine impurity, N-Nitroso-N-methyl-4-aminobutyric acid.

March 9, 2019
·
8 min read
Pharm Country

Buinewicz Plastic Surgery & Medspa is Helping Men Wave Goodbye to Erectile Dysfunction with Cutting-edge GAINSWave® Treatment

Brian R. Buinewicz of Buinewicz Plastic surgery & Medspa is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED).

March 9, 2019
·
2 min read
Job Trends

Revolutionary Erectile Dysfunction Treatment, GAINSWave®, Now Offered by Genesys Medical Institute in Utah

Genesys Medical Institute is implementing a non-invasive and drug free solution for Erectile Dysfunction called GAINSWave, which boasts a 75% success rate.

March 9, 2019
·
2 min read
Policy

VIVA Physicians Selects NAMSA as Statistical Analytic Group to Evaluate the Safety of Paclitaxel Drug-Eluting Technologies in PAD

VIVA Physicians announced the selection of NAMSA as the independent statistical analysis group to examine individual patient-level data associated with paclitaxel-coated balloons and stent trials used in the treatment of peripheral artery disease in the superficial femoral artery.

March 9, 2019
·
3 min read
Business

WOHASU® convenes H-20 Government Track in Lisbon, Portugal to discuss how governments can implement the science of happiness into public policy

WOHASU® announced that the third annual H-20 Government Summit, sponsored by FreeBalance® and WOHASU, will hold its first international edition on March 12, 2019, in Lisbon, Portugal.

March 9, 2019
·
2 min read